Eurofins Scientific SE (ERFSF)
| Previous close | 79.97 |
| Open | 83.39 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 83.39 - 83.39 |
| 52-week range | 76.09 - 151.96 |
| Volume | |
| Avg. volume | 379 |
| Market cap | 16.038B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 20.29 |
| EPS (TTM) | 4.11 |
| Earnings date | N/A |
| Forward dividend & yield | 1.05 (1.03%) |
| Ex-dividend date | 05 Jul 2022 |
| 1y target est | N/A |
- Business Wire
Gold Standard Diagnostics, a Eurofins Technologies Company, Announces a PCR Assay for the Detection of the Monkeypox and Orthopox Virus
LUXEMBOURG, June 23, 2022--Gold Standard Diagnostics Europe continues its response to the threat of emerging infectious diseases by developing a new multiplex Real-time PCR assay for the detection of the monkeypox virus and its differentiation from other orthopox viruses.
- Business Wire
Eurofins Successfully Prices New €600m 7-Year 4%-Coupon Senior Unsecured Bonds
LUXEMBOURG, June 21, 2022--Regulatory News: Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3/positive by Moody’s and BBB/stable- by Fitch, "Eurofins"), a global leader in bioanalytical testing, announces that it has successfully raised €600m in its latest senior unsecured Euro-denominated public bond issuance (the "Bonds"). The Bonds have a 7-year maturity (due on 6 July 2029) and will bear an annual fixed rate coupon of 4%. The transaction was well received and was more than 2.3x over-subsc
- Business Wire
Eurofins Announces Its Intention to Issue New Euro Senior Bonds to Refinance Part of Its Existing Hybrid Bonds
LUXEMBOURG, June 21, 2022--Regulatory News: Eurofins Scientific (EUFI.PA, rated Baa3/positive by Moody’s and BBB-/stable by Fitch rating, "Eurofins") (Paris:ERF), a global leader in bioanalytical testing, announces today:
